Filing Details
- Accession Number:
- 0000874015-20-000084
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-29 21:47:59
- Reporting Period:
- 2020-06-25
- Accepted Time:
- 2020-06-29 21:47:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
874015 | Ionis Pharmaceuticals Inc | IONS | Pharmaceutical Preparations (2834) | 330336973 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1335073 | Breaux Castleman | C/O Ionis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad CA 92010 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-06-25 | 10,000 | $26.66 | 25,183 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-06-25 | 10,000 | $60.00 | 15,183 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Director Stock Option (right to buy) | Disposition | 2020-06-25 | 10,000 | $0.00 | 10,000 | $26.66 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
12,500 | 2017-06-25 | 2023-06-24 | No | 4 | M | Direct |
Footnotes
- Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on March 5, 2020.